Novel common integration sites targeted by mouse mammary tumor virus insertion in mammary tumors have oncogenic activity

PLoS ONE

Volumn 6, Issue 11, 2011, Pages

  Kim, Hyoung H ^a   van den Heuvel, A Pieter J ^a   Schmidt, John W ^a   Ross, Susan R ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTXR1 GENE; ARHGAP18 GENE; ARTICLE; BREAST CARCINOGENESIS; BREAST CELL; BREAST TUMOR; CANCER CELL CULTURE; CELL GROWTH; CELL PROLIFERATION; CELL STRUCTURE; CELL TRANSFORMATION; CONTROLLED STUDY; DISEASE ASSOCIATION; EXPRESSION VECTOR; FGF GENE; GENE INSERTION; GENE TARGETING; LIGAND BINDING; MOUSE; MOUSE MAMMARY TUMOR ONCOVIRUS; NONHUMAN; PRKACA GENE; TRANSCRIPTION FACTOR 7 LIKE 2 GENE; VIRAL GENE DELIVERY SYSTEM; VIRUS CARCINOGENESIS; VIRUS DNA CELL DNA INTERACTION; VIRUS GENE; WNT GENE; ANIMAL; CELL SHAPE; EXPERIMENTAL NEOPLASM; FEMALE; GENE EXPRESSION REGULATION; GENETICS; PHYSIOLOGY; TUMOR CELL CULTURE; TUMOR GENE; VIROLOGY;

MOUSE MAMMARY TUMOR VIRUS; MURINAE; MUS;

ANTXR1 PROTEIN, MOUSE; RECEPTOR; TCF7 PROTEIN, MOUSE; TRANSCRIPTION FACTOR 7; TUMOR MARKER;

ANIMALS; CELL PROLIFERATION; CELL SHAPE; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, NEOPLASM; MAMMARY NEOPLASMS, ANIMAL; MAMMARY TUMOR VIRUS, MOUSE; MICE; MUTAGENESIS, INSERTIONAL; RECEPTORS, PEPTIDE; T CELL TRANSCRIPTION FACTOR 1; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL; VIRUS INTEGRATION;

EID: 80455158293     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0027425     Document Type: Article

References (43)

1. Callahan R, Smith GH, (2000) MMTV-induced mammary tumorigenesis: gene discovery, progression to malignancy and cellular pathways. Oncogene 19: 992-1001.
2. Callahan R, Smith GH, (2008) Common integration sites for MMTV in viral induced mouse mammary tumors. J Mammary Gland Biol Neoplasia 13: 309-321.
3. Callahan R, Smith GH, (2008) The mouse as a model for mammary tumorigenesis: history and current aspects. J Mammary Gland Biol Neoplasia 13: 269.
4. Theodorou V, Kimm MA, Boer M, Wessels L, Theelen W, et al. (2007) MMTV insertional mutagenesis identifies genes, gene families and pathways involved in mammary cancer. Nat Genet 39: 759-769.
5. Gattelli A, Zimberlin MN, Meiss RP, Castilla LH, Kordon EC, (2006) Selection of early-occurring mutations dictates hormone-independent progression in mouse mammary tumor lines. Journal of virology 80: 11409-11415.
6. Katz E, Lareef MH, Rassa JC, Grande SM, King LB, et al. (2005) MMTV Env encodes an ITAM responsible for transformation of mammary epithelial cells in three-dimensional culture. J Exp Med 201: 431-439.
7. Ross SR, Schmidt JW, Katz E, Cappelli L, Hultine S, et al. (2006) An immunoreceptor tyrosine activation motif in the mouse mammary tumor virus envelope protein plays a role in virus-induced mammary tumors. Journal of virology 80: 9000-9008.
8. Suzuki T, Shen H, Akagi K, Morse HC, Malley JD, et al. (2002) New genes involved in cancer identified by retroviral tagging. Nat Genet 32: 166-174.
9. Mikkers H, Allen J, Knipscheer P, Romeijn L, Hart A, et al. (2002) High-throughput retroviral tagging to identify components of specific signaling pathways in cancer. Nat Genet 32: 153-159.
10. Mitchell RS, Beitzel BF, Schroder AR, Shinn P, Chen H, et al. (2004) Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences. PLoS Biol 2: E234.
11. Wu X, Li Y, Crise B, Burgess SM, (2003) Transcription start regions in the human genome are favored targets for MLV integration. Science 300: 1749-1751.
12. Dupuy AJ, Akagi K, Largaespada DA, Copeland NG, Jenkins NA, (2005) Mammalian mutagenesis using a highly mobile somatic Sleeping Beauty transposon system. Nature 436: 221-226.
13. Akagi K, Suzuki T, Stephens RM, Jenkins NA, Copeland NG, (2004) RTCGD: retroviral tagged cancer gene database. Nucleic Acids Res 32: D523-527.
14. Schroder AR, Shinn P, Chen H, Berry C, Ecker JR, et al. (2003) HIV-1 integration in the human genome favors active genes and local hotspots. Cell 110: 521-529.
15. Ross SR, Schmidt JW, Katz E, Cappelli L, Hultine S, et al. (2006) An immunoreceptor tyrosine activation motif in the Mouse Mammary Tumor Virus envelope protein plays a role in virus-induced mammary tumors. J Virol 80: 9000-9008.
16. Shackleford GM, Varmus HE, (1988) Construction of a clonable, infectious, and tumorigenic mouse mammary tumor virus provirus and a derivative genetic vector. Proc Natl Acad USA 85: 9655-9659.
17. Chatterjee G, Rosner A, Han Y, Zelazny ET, Li B, et al. (2002) Acceleration of mouse mammary tumor virus-induced murine mammary tumorigenesis by a p53 172H transgene: influence of FVB background on tumor latency and identification of novel sites of proviral insertion. Am J Pathol 161: 2241-2253.
18. Wu C, Orozco C, Boyer J, Leglise M, Goodale J, et al. (2009) BioGPS: an extensible and customizable portal for querying and organizing gene annotation resources. Genome Biol 10: R130.
19. Merlo GR, Venesio T, Taverna D, Marte BM, Callahan R, et al. (1994) Growth suppression of normal mammary epithelial cells by wild-type p53. Oncogene 9: 443-453.
20. Merlo GR, Graus-Porta D, Cella N, Marte BM, Taverna D, et al. (1996) Growth, differentiation and survival of HC11 mammary epithelial cells: diverse effects of receptor tyrosine kinase-activating peptide growth factors. Eur J Cell Biol 70: 97-105.
21. Debnath J, Muthuswamy SK, Brugge JS, (2003) Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. Methods 30: 256-268.
22. Nusse R, (1997) A versatile transcriptional effector of Wingless signaling. Cell 89: 321-323.
23. Wodarz A, Nusse R, (1998) Mechanisms of Wnt signaling in development. Annu Rev Cell Dev Biol 14: 59-88.
24. Abrami L, Kunz B, Deuquet J, Bafico A, Davidson G, et al. (2008) Functional interactions between anthrax toxin receptors and the WNT signalling protein LRP6. Cell Microbiol 10: 2509-2519.
25. van Leeuwen IM, Byrne HM, Jensen OE, King JR, (2007) Elucidating the interactions between the adhesive and transcriptional functions of beta-catenin in normal and cancerous cells. J Theor Biol 247: 77-102.
26. Jho EH, Zhang T, Domon C, Joo CK, Freund JN, et al. (2002) Wnt/beta-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway. Mol Cell Biol 22: 1172-1183.
27. Ross SR, (2011, in press) Mouse mammary tumor virus and cancer. In: Robertson ES, editors. Cancer Associated Viruses NY Springer Science and Business Media.
28. Bradley KA, Mogridge J, Mourez M, Collier RJ, Young JA, (2001) Identification of the cellular receptor for anthrax toxin. Nature 414: 225-229.
29. Scobie HM, Rainey GJ, Bradley KA, Young JA, (2003) Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor. Proc Natl Acad Sci U S A 100: 5170-5174.
30. St Croix B, Rago C, Velculescu V, Traverso G, Romans KE, et al. (2000) Genes expressed in human tumor endothelium. Science 289: 1197-1202.
31. Carson-Walter EB, Watkins DN, Nanda A, Vogelstein B, Kinzler KW, et al. (2001) Cell surface tumor endothelial markers are conserved in mice and humans. Cancer Res 61: 6649-6655.
32. Wei W, Lu Q, Chaudry GJ, Leppla SH, Cohen SN, (2006) The LDL receptor-related protein LRP6 mediates internalization and lethality of anthrax toxin. Cell 124: 1141-1154.
33. Verma K, Gu J, Werner E, (2011) Tumor endothelial marker 8 amplifies canonical Wnt signaling in blood vessels. PLoS ONE 6: e22334.
34. Werner E, Kowalczyk AP, Faundez V, (2006) Anthrax toxin receptor 1/tumor endothelium marker 8 mediates cell spreading by coupling extracellular ligands to the actin cytoskeleton. J Biol Chem 281: 23227-23236.
35. Brantjes H, Barker N, van Es J, Clevers H, (2002) TCF: Lady Justice casting the final verdict on the outcome of Wnt signalling. Biol Chem 383: 255-261.
36. Angus-Hill ML, Elbert KM, Hidalgo J, Capecchi MR, (2011) T-cell factor 4 functions as a tumor suppressor whose disruption modulates colon cell proliferation and tumorigenesis. Proc Natl Acad Sci U S A 108: 4914-4919.
37. Tsedensodnom O, Koga H, Rosenberg SA, Nambotin SB, Carroll JJ, et al. (2011) Identification of T-cell factor-4 isoforms that contribute to the malignant phenotype of hepatocellular carcinoma cells. Exp Cell Res 317: 920-931.
38. Maeda M, Hasegawa H, Hyodo T, Ito S, Asano E, et al. (2011) ARHGAP18, a GTPase activating protein for RhoA, controls cell shape, spreading and motility. Mol Biol Cell.
39. Naidu R, Yip CH, Taib NA, (2011) Genetic variations in transcription factor 7-like 2 (TCF7L2) gene: association of TCF7L2 rs12255372(G/T) or rs7903146(C/T) with breast cancer risk and clinico-pathological parameters. Med Oncol.
40. Goode EL, Szabo C, Prokunina-Olsson L, Vierkant RA, Fredericksen ZS, et al. (2009) No association between a candidate TCF7L2 variant and risk of breast or ovarian cancer. BMC Cancer 9: 312.
41. Burwinkel B, Shanmugam KS, Hemminki K, Meindl A, Schmutzler RK, et al. (2006) Transcription factor 7-like 2 (TCF7L2) variant is associated with familial breast cancer risk: a case-control study. BMC Cancer 6: 268.
42. Buggiano V, Levy CS, Gattelli A, Cirio MC, Marfil M, et al. (2002) Origin and progression of pregnancy-dependent mammary tumors induced by new mouse mammary tumor virus variants. Breast Cancer Res Treat 75: 191-202.
43. Aranda V, Haire T, Nolan ME, Calarco JP, Rosenberg AZ, et al. (2006) Par6-aPKC uncouples ErbB2 induced disruption of polarized epithelial organization from proliferation control. Nat Cell Biol 8: 1235-1245.